Targeting the NF-κB pathway as a potential regulator of immune checkpoints in cancer immunotherapy.
Ebrahimi N, Abdulwahid ARR, Mansouri A, Karimi N, Bostani RJ, Beiranvand S, Adelian S, Khorram R, Vafadar R, Hamblin MR, Aref AR.
Ebrahimi N, et al. Among authors: hamblin mr.
Cell Mol Life Sci. 2024 Feb 29;81(1):106. doi: 10.1007/s00018-023-05098-8.
Cell Mol Life Sci. 2024.
PMID: 38418707
Free PMC article.
Review.